Reinhard J. Ambros - 23 Jul 2025 Form 4 Insider Report for Rein Therapeutics, Inc. (RNTX)

Role
Director
Signature
/s/ Brian Windsor, attorney-in-fact for Reinhard J. Ambros
Issuer symbol
RNTX
Transactions as of
23 Jul 2025
Net transactions value
$0
Form type
4
Filing time
23 Jul 2025, 19:36:52 UTC
Previous filing
06 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ambros Reinhard J. Director C/O REIN THERAPEUTICS, INC, 12407 N. MOPAC EXPY. SUITE 250 #390, AUSTIN /s/ Brian Windsor, attorney-in-fact for Reinhard J. Ambros 23 Jul 2025 0001709690

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNTX Stock Option (right to buy) Award $0 +17,500 $0.000000 17,500 23 Jul 2025 Common Stock 17,500 $1.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service.